Human Vaccines & Immunotherapeutics (Nov 2022)

Hepatitis A in the Eastern Mediterranean Region: a comprehensive review

  • Selim Badur,
  • Serdar Öztürk,
  • Mohammad AbdelGhany,
  • Mansour Khalaf,
  • Youness Lagoubi,
  • Onur Ozudogru,
  • Kashif Hanif,
  • Debasish Saha

DOI
https://doi.org/10.1080/21645515.2022.2073146
Journal volume & issue
Vol. 18, no. 5

Abstract

Read online

Introduction With 583 million inhabitants, the Eastern Mediterranean Region (EMR) is a worldwide hub for travel, migration, and food trade. However, there is a scarcity of data on the epidemiology of the hepatitis A virus (HAV). Methods The MEDLINE and grey literature were systematically searched for HAV epidemiological data relevant to the EMR region published between 1980 and 2020 in English, French, or Arabic. Results Overall, 123 publications were extracted. The proportion of HAV cases among acute viral hepatitis cases was high. HAV seroprevalence rate ranged from 5.7% to 100.0% and it was decreasing over time while the average age at infection increased. Conclusion In the EMR, HAV remains a significant cause of acute viral hepatitis. The observed endemicity shift will likely increase disease burden as the population ages. Vaccinating children and adopting sanitary measures are still essential to disease prevention; vaccinating at-risk groups might reduce disease burden even further.

Keywords